MedPath

Teoxane SA

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults

Not Applicable
Recruiting
Conditions
Infraorbital Hollows
First Posted Date
2024-12-27
Last Posted Date
2025-01-28
Lead Sponsor
Teoxane SA
Target Recruit Count
260
Registration Number
NCT06749587
Locations
🇨🇳

Guangdong Second Provincial General Hospital, Guangzhou, China

RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)

Not Applicable
Active, not recruiting
Conditions
Aging
Pain
Interventions
Device: RHA® Redensity with new anesthetic agent
Device: RHA® Redensity with lidocaine
First Posted Date
2024-04-22
Last Posted Date
2025-04-11
Lead Sponsor
Teoxane SA
Target Recruit Count
20
Registration Number
NCT06378086
Locations
🇺🇸

United States, Birmingham, Alabama, United States

🇵🇷

Puerto Rico, San Juan, Puerto Rico

🇺🇸

United States, New York, New York, New York, United States

TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults

Not Applicable
Recruiting
Conditions
Nasolabial Folds
Interventions
Device: injection in NLF
First Posted Date
2024-04-16
Last Posted Date
2024-04-16
Lead Sponsor
Teoxane SA
Target Recruit Count
390
Registration Number
NCT06367634
Locations
🇨🇳

Guangdong Second Provincial General Hospital, Guangzhou, China

Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face

Not Applicable
Recruiting
Conditions
Chin Retrusion
Aging
Interventions
Device: TEOSYAL® TPVM
Device: COMPARATOR
First Posted Date
2023-08-14
Last Posted Date
2025-04-03
Lead Sponsor
Teoxane SA
Target Recruit Count
155
Registration Number
NCT05986630
Locations
🇨🇭

Care- Geneva, Geneva, Switzerland

TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Not Applicable
Conditions
Fine Lines of the Face and Neck
Skin Aging
Interventions
Device: TEOSYAL RHA® 1 and TEOSYAL® PureSense Redensity 1 (needle)
Device: TEOSYAL RHA® 1
Device: TEOSYAL RHA® 1 and TEOSYAL® PureSense Redensity 1 (cannula)
First Posted Date
2022-04-27
Last Posted Date
2022-05-04
Lead Sponsor
Teoxane SA
Target Recruit Count
67
Registration Number
NCT05349799
Locations
🇪🇸

Site 4, Alicante, Spain

🇪🇸

Site 3, Barcelona, Spain

🇪🇸

Site 1, Bilbao, Spain

and more 1 locations

RHA®4 for Midface Volume Deficiency

Completed
Conditions
Cheek Augmentation
Correction of Age-related Midface Contour Deficiencies
First Posted Date
2021-11-24
Last Posted Date
2025-03-18
Lead Sponsor
Teoxane SA
Target Recruit Count
201
Registration Number
NCT05133739
Locations
🇺🇸

United States, Massachusetts, Chestnut Hill, Massachusetts, United States

RHA® 4 NLF Cannula

Not Applicable
Completed
Conditions
Wrinkle
Nasolabial Fold
Aging
Interventions
Device: Split-face injection of RHA® 4 with a needle (TSK 27G x ½") into the contralateral NLF.
Device: Split-face injection of RHA® 4 with a cannula into a single NLF.
First Posted Date
2021-02-15
Last Posted Date
2023-03-09
Lead Sponsor
Teoxane SA
Target Recruit Count
50
Registration Number
NCT04754646
Locations
🇺🇸

United States, California, Encinitas, California, United States

🇺🇸

United States, North Carolina, Chapel Hill, North Carolina, United States

🇺🇸

United States, Florida, West Palm Beach, Florida, United States

and more 1 locations

RHA® 3 Versus Restylane-L® for Lip Augmentation

Completed
Conditions
Lip
Lip Augmentation
Interventions
Device: RHA 3
Device: Restylane-L
First Posted Date
2020-09-07
Last Posted Date
2025-02-03
Lead Sponsor
Teoxane SA
Target Recruit Count
202
Registration Number
NCT04540913
Locations
🇺🇸

United States, Florida, Bradenton, Florida, United States

RHA® 4 With New Anesthetic - Nasolabial Folds

Not Applicable
Completed
Conditions
Aging
Pain
Interventions
Device: RHA®4 with new anesthetic agent
Device: RHA®4-Lidocaine
First Posted Date
2019-09-12
Last Posted Date
2022-01-24
Lead Sponsor
Teoxane SA
Target Recruit Count
30
Registration Number
NCT04087395
Locations
🇺🇸

Florida, Coral Gables, Florida, United States

🇺🇸

California, Beverly Hills, California, United States

🇺🇸

Illinois, Chicago, Illinois, United States

RHA® Redensity With New Anesthetic Agent - Perioral Rhytids

Not Applicable
Completed
Conditions
Aging
Pain
Interventions
Device: RHA® Redensity with new anesthetic agent
Device: RHA® Redensity with lidocaine
First Posted Date
2019-08-28
Last Posted Date
2022-01-24
Lead Sponsor
Teoxane SA
Target Recruit Count
30
Registration Number
NCT04069585
Locations
🇺🇸

California, Beverly Hills, California, United States

🇺🇸

Florida, Coral Gables, Florida, United States

🇺🇸

Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath